Skip to content
10-Q

Quarterly Report

RANI THERAPEUTICS HOLDINGS, INC. RANI

0000950170-25-070382

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Long Term Debt Q1 2025 · Mar 31, 2025 $5.92M
Long Term Debt Q1 2025 · Dec 31, 2024 $9.61M
Short Term Debt Q1 2025 · Mar 31, 2025 $15M
Short Term Debt Q1 2025 · Dec 31, 2024 $15M
Stockholders Equity Q1 2025 · Mar 31, 2025 −$3.06M
Stockholders Equity Q1 2025 · Dec 31, 2024 $1.99M
Current Liabilities Q1 2025 · Mar 31, 2025 $20.13M
Current Liabilities Q1 2025 · Dec 31, 2024 $19.89M
Total Liabilities Q1 2025 · Mar 31, 2025 $29.47M
Total Liabilities Q1 2025 · Dec 31, 2024 $33.14M
Current Assets Q1 2025 · Mar 31, 2025 $17.78M
Current Assets Q1 2025 · Dec 31, 2024 $29.74M
Total Assets Q1 2025 · Mar 31, 2025 $24.13M
Total Assets Q1 2025 · Dec 31, 2024 $36.63M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $3.76M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $6.88M
Shares Diluted Q1 2025 · Mar 31, 2024 26.03M sh
Capex Q1 2025 · Mar 31, 2024 $18K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$9.4M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.29
Eps Basic Q1 2025 · Mar 31, 2024 −$0.29
Sga Expense Q1 2025 · Mar 31, 2024 $6.45M
Rd Expense Q1 2025 · Mar 31, 2024 $7.59M
Net Income Q1 2025 · Mar 31, 2024 −$7.48M
Operating Income Q1 2025 · Mar 31, 2024 −$14.03M
Revenue Q1 2025 · Mar 31, 2024 $0